CD47 and oral cavity squamous cell carcinoma: Pai and Zhang et al. demonstrated that knockdown of CD47 gene in oral squamous cell carcinoma and hepatocellular carcinoma could down-regulate the resistance caused by the above glycolytic pathway to improve therapeutic efficacy, respectively [33, 34].